Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Source:http://linkedlifedata.com/resource/pubmed/id/19280324

Download in:

View as

General Info

PMID
19280324